Immunic, inc. to announce financial results for the second quarter ended june 30, 2023, and provide corporate update

– webcast to be held at 8:00 am et on august 3, 2023 – new york , july 27, 2023 /prnewswire/ -- immunic, inc.  (nasdaq: imux), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced that the company will release its financial results for the second quarter ended june 30, 2023, including a corporate update, on thursday, august 3, 2023, before the opening of the u.s. financial markets. a webcast will follow at 8:00 am et.
IMUX Ratings Summary
IMUX Quant Ranking